Form 4: Artivion Director Elizabeth Hoff Receives Stock Grant

Artivion, Inc. director Elizabeth A. Hoff was granted 7,576 shares of common stock as part of an equity incentive plan.

Summary

• Director Elizabeth A. Hoff acquired 7,576 shares of Artivion, Inc. (AORT) common stock.
• The shares were granted at a price of $0 per share.
• The grant is a Restricted Stock Award (RSA) issued under the company's Equity and Cash Incentive Plan.
• Following this transaction, the director's total beneficial ownership is 34,765 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• The director's increased equity stake aligns her interests more closely with those of shareholders.

Negatives

• None identified.

Risks

• The vesting of the shares is subject to the terms of the Equity and Cash Incentive Plan, which may include performance or service conditions.

Future Outlook

The shares are scheduled to vest on May 18, 2027, subject to the terms of the company's incentive plan.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to incentivize long-term board commitment and shareholder alignment in the medical device sector.

Comparison to Industry Standards

• The grant of restricted stock to non-employee directors is a common practice among mid-cap medical technology companies to ensure retention and alignment.
• The structure of the grant is consistent with standard equity compensation packages for board members in the healthcare industry.

Stakeholder Impact

• Shareholders benefit from increased alignment between board members and company performance.

Next Steps

• Vesting of the 7,576 shares on May 18, 2027.

Key Dates

Keywords

Artivion, AORT, Form 4, Insider Transaction, Equity Incentive Plan, Director Compensation